pI: 9.5135 |
Length (AA): 1395 |
MW (Da): 151016 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
825 | 1135 | 2bfx (A) | 91 | 349 | 16.00 | 0 | 0.8 | 0.15 | 0.64 |
897 | 1071 | 2gph (A) | 53 | 228 | 14.00 | 0.000000017 | 0.16 | 0.28 | -0.42 |
200 | 341 | 2mu3 (A) | 4 | 180 | 36.00 | 0.22 | 0.07 | 0.0412921 | 0.95 |
286 | 407 | 2mqa (A) | 25 | 141 | 17.00 | 0 | 0.01 | 0.196255 | -0.01 |
984 | 1376 | 4ped (A) | 259 | 640 | 42.00 | 0 | 1 | 0.84122 | -1.02 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Fritz HM Sibley/Greg |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_127778)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G01660 | ABC transporter 1 |
Babesia bovis | BBOV_IV000470 | ABC1family protein, putative |
Brugia malayi | Bm1_02730 | chaperone-activity of bc1 complex-like, mitochondrial, putative |
Candida albicans | CaO19.3331 | similar to S. cerevisiae mitochondrial chaperonin ABC1 (YGL119W) involved in electron transport |
Candida albicans | CaO19.10842 | similar to S. cerevisiae mitochondrial chaperonin ABC1 (YGL119W) involved in electron transport |
Caenorhabditis elegans | CELE_C35D10.4 | Protein COQ-8 |
Cryptosporidium hominis | Chro.80377 | ABC1 family |
Cryptosporidium parvum | cgd8_3250 | ABC1 like protein kinase |
Dictyostelium discoideum | DDB_G0288749 | ABC1 family protein kinase |
Drosophila melanogaster | Dmel_CG32649 | CG32649 gene product from transcript CG32649-RA |
Echinococcus granulosus | EgrG_000395100 | ABC domain containing protein kinase |
Echinococcus multilocularis | EmuJ_000395100 | ABC domain containing protein kinase |
Homo sapiens | ENSG00000163050 | aarF domain containing kinase 3 |
Homo sapiens | ENSG00000123815 | aarF domain containing kinase 4 |
Leishmania braziliensis | LbrM.35.4770 | ABC1 protein, putative |
Leishmania donovani | LdBPK_364750.1 | ABC1 protein, putative |
Leishmania infantum | LinJ.36.4750 | ABC1 protein, putative |
Leishmania major | LmjF.36.4530 | ABC1 protein, putative |
Mycobacterium leprae | ML0640c | Probable conserved ATP-binding protein ABC transporter |
Mus musculus | ENSMUSG00000003762 | aarF domain containing kinase 4 |
Mus musculus | ENSMUSG00000026489 | aarF domain containing kinase 3 |
Mycobacterium tuberculosis | Rv3197 | Probable conserved ATP-binding protein ABC transporter |
Mycobacterium ulcerans | MUL_2510 | ABC transporter ATP-binding protein |
Neospora caninum | NCLIV_021150 | ABC1 domain-containing protein, putative |
Oryza sativa | 4327271 | Os01g0318700 |
Plasmodium berghei | PBANKA_1427300 | ABC1 family, putative |
Plasmodium falciparum | PF3D7_0810200 | ABC1 family, putative |
Plasmodium knowlesi | PKNH_1430500 | ABC1 family, putative |
Plasmodium vivax | PVX_123265 | ABC1 family, putative |
Plasmodium yoelii | PY01655 | ABC1 family, putative |
Saccharomyces cerevisiae | YGL119W | Coq8p |
Schistosoma japonicum | Sjp_0038550 | ko:K08869 aarF domain-containing kinase, putative |
Schistosoma mansoni | Smp_021330.2 | ABC transporter |
Schistosoma mansoni | Smp_021330.1 | ABC transporter |
Schmidtea mediterranea | mk4.000062.08 | Chaperone activity of bc1 complex-like, mitochondrial |
Schmidtea mediterranea | mk4.000062.10 | |
Trypanosoma brucei gambiense | Tbg972.10.12090 | ABC1 protein, putative |
Trypanosoma brucei | Tb927.10.9900 | ABC1 protein, putative |
Trypanosoma congolense | TcIL3000_10_8460 | ABC1 protein, putative |
Trypanosoma cruzi | TcCLB.503847.90 | ABC1 protein, putative |
Trypanosoma cruzi | TcCLB.504103.100 | ABC1 protein, putative |
Toxoplasma gondii | TGME49_203940 | ABC1 protein |
Theileria parva | TP01_0065 | ABC1 protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3250 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.10.9900 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9900 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9900 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.9900 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C35D10.4 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_203940 this record | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | aarF domain containing kinase 4 | Compounds | References |
Homo sapiens | aarF domain containing kinase 3 | Compounds | References |